Forums

This forum is not active, and new posts may not be made in it.

Antonio 42 3 Redlands	Actimmune (interferon Gamma 1-b): clinical trial showed that patents with IPF ho received Actimmune did not beneit. 7/2/2007 12:27:21 PM
	FDA notified healthcare professionals of the early termination of the INSPIRE clinical study of Actimmune for idiopathic pulmonary fibrosis (IPF). The study was stopped because an interim analysis showed that patients with IPF who received Actimmune did not benefit. The trial compared survival in patients getting actimmune or an inactive injection (placebo). An analysis showed that 14.5% of patients treated with placebo. Actimmune is not approved by the FDA to treat IPF. Read the complete Medwatch 2007 Safety summary, including a link to the Public Health Advisory and Drug Information Page, at: http//www.fda.gov/medwatch/safety/2007/safety07.htm#Actimmune
	HEALTHGATES.NET The gateway to the world of health information. Be the first one to know!
	+0

Gerry 476 111 Makati	Re: Actimmune (interferon Gamma 1-b): clinical trial showed that patents with IPF ho received Actimmune did not beneit. 7/2/2007 1:49:41 PM
	Please upload your photo and tell us more about yourself and your profession. Thanks. Gerry
	http://grp39.sulit.com.phhttp://www.moreniche.com/join.html?w=135313&ttp=3http://www.globalcashformula.com/richpal
	+0

Menu